Rio Honma Selected Research

Platinum

1/2021

Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rio Honma Research Topics

Disease

3	Neoplasms (Cancer) 09/2023 - 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 09/2023
1	Thyroid Neoplasms (Thyroid Cancer) 07/2023
1	Disease Progression 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 08/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 09/2016
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2011
1	Neuroendocrine Carcinoma 05/2011

Drug/Important Bio-Agent (IBA)

1	Prostate-Specific Antigen (Semenogelase)IBA 09/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2023
1	lenvatinibIBA 07/2023
1	Cetuximab (Erbitux)FDA Link 01/2021
1	PlatinumIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	OligosaccharidesIBA 01/2015
1	FucosyltransferasesIBA 01/2015
1	AsparagineIBA 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	EnzymesIBA 01/2015
1	Bevacizumab (Avastin)FDA Link 05/2011

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 08/2018 - 05/2011
1	Therapeutics 09/2016